Structured treatment interruptions following immediate initiation of HAART in eight patients with acute HIV-1 seroconversion. (Record no. 16487235)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 01830 a2200553 4500 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250515035250.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 200610s 0 0 eng d |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
International Standard Serial Number | 0949-2321 |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | NLM |
Language of cataloging | eng |
Transcribing agency | NLM |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | Vogel, M |
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Date of production, publication, distribution, manufacture, or copyright notice | 20061003 |
245 00 - TITLE STATEMENT | |
Title | Structured treatment interruptions following immediate initiation of HAART in eight patients with acute HIV-1 seroconversion. |
Medium | [electronic resource] |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Name of publisher, distributor, etc. | European journal of medical research |
Date of publication, distribution, etc. | Jul 2006 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 273-8 p. |
Other physical details | digital |
500 ## - GENERAL NOTE | |
General note | Publication Type: Comparative Study; Journal Article; Research Support, N.I.H., Extramural |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Acute Disease |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Adult |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Anti-HIV Agents |
General subdivision | therapeutic use |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Antiretroviral Therapy, Highly Active |
General subdivision | methods |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | CD4-Positive T-Lymphocytes |
General subdivision | immunology |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | CD8-Positive T-Lymphocytes |
General subdivision | immunology |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Drug Therapy, Combination |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Female |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Follow-Up Studies |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | HIV Seropositivity |
General subdivision | drug therapy |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | HIV-1 |
General subdivision | genetics |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Histocompatibility Testing |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Humans |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Lamivudine |
General subdivision | therapeutic use |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Lopinavir |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Male |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Pyrimidinones |
General subdivision | therapeutic use |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | RNA, Viral |
General subdivision | genetics |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Retrospective Studies |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Stavudine |
General subdivision | therapeutic use |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Treatment Outcome |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Zidovudine |
General subdivision | therapeutic use |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Lichterfeld, M |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Kaufmann, D E |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Mui, S K |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Altfeld, M |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Voigt, E |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Ahlenstiel, G |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Kupfer, B |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Walker, B |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Spengler, U |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Rockstroh, J K |
773 0# - HOST ITEM ENTRY | |
Title | European journal of medical research |
Related parts | vol. 11 |
-- | no. 7 |
-- | p. 273-8 |
No items available.